
Publication
International Restructuring Newswire
Welcome to the Q3 2025 edition of the Norton Rose Fulbright International Restructuring Newswire.
Canada | Publication | April 20, 2020 – 5 PM ET
Around the globe, pharmaceutical and medical device companies are helping in the fight of the COVID-19 pandemic. Many of these companies may have patents pertaining to technology that could be used for the benefit of the broader public during this time of crisis, such as patents on ventilators, diagnostic tests, pharmaceuticals or personal protective equipment. Governments around the globe have mechanisms in place that can mandate the use of patented inventions during a national emergency.
The reference guide provides a high-level overview of the governmental authorization provisions in Canada, the United States, France, Germany, the Netherlands, the United Kingdom, Hong Kong, China, Singapore and Australia.
Publication
Welcome to the Q3 2025 edition of the Norton Rose Fulbright International Restructuring Newswire.
Publication
Canada is well-positioned to be a leader in Carbon Capture and Storage (“CCS”).
Publication
Hydrogen has long been of interest as a low emission or emission-free energy source. For Canada, its use, production, and transportation loom as a new energy disruptor. As a fuel, hydrogen is a clean power source that when combusted, produces no carbon dioxide emissions, only water vapour. Some methods used to produce hydrogen do, however, generate emissions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025